
|Articles|May 1, 2018
- Pharmaceutical Executive-05-01-2018
- Volume 38
- Issue 5
Pharmaceutical Executive, May 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Brands of the Year: Promise and Challengeabout 8 years ago
Gauging the Collaborative Spirit in European Healthabout 8 years ago
Gottlieb Tackles Drug Competition & Costsabout 8 years ago
Deploying the Cloud in GxP Environmentsabout 8 years ago
So Much Depends on the Physicianabout 8 years ago
Bridging Science & Strategy: An Investor’s Eyeabout 8 years ago
Patient Empowerment and the Future of Pharma Advertisingabout 8 years ago
Closing Pharma’s Digital Divideabout 8 years ago
Patient KOLs: Their Guide to Entering Crowded Marketsabout 8 years ago
The Total Care PackageAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
The Power of Better Questions: How Great Leaders Balance Risk, Growth and Curiosity
5




